The value of HE4 and its combined detection on predicting recurrence and cancer death in patients with non–small cell lung cancer
There was an independent correlation between high serum HE4 levels at admission and an increased risk of recurrence or metastasis and cancer death from NSCLC that supports serum HE4 as a biomarker for survival prognosis after NSCLC treatment.
Authors
- Jianhong Xiao (ORCID: https://orcid.org/0009-0000-8633-2767)
- Guohua Guo (ORCID: https://orcid.org/0009-0009-5884-5253)
- Hui‐Ming Lin (ORCID: https://orcid.org/0000-0003-4892-6008)
- Lijun Li (ORCID: https://orcid.org/0000-0001-7122-5889)
- Junhua Chen (ORCID: https://orcid.org/0000-0002-0947-6879)
- Xiaojie Zheng
- Bin Song (ORCID: https://orcid.org/0000-0001-8657-4264)
Institutions
- Fujian Medical University (CN)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1093/labmed/lmaf007
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00